Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells

In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2001-04, Vol.276 (17), p.14466-14473
Hauptverfasser: Watanabe, H, de Caestecker, M P, Yamada, Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14473
container_issue 17
container_start_page 14466
container_title The Journal of biological chemistry
container_volume 276
creator Watanabe, H
de Caestecker, M P
Yamada, Y
description In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation.
doi_str_mv 10.1074/jbc.M005724200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17848265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17848265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</originalsourceid><addsrcrecordid>eNpFkc1u1DAUhbMAtaVlyxJ5xaqZ-iceJ8tqKAVRhATDOrqxbzJuEzvYDtM-Im-Fh45UbyxZx985956ieMfoilFVXd13evWNUql4xSl9VZxRylnZcFmfFm9ivKf5VA07KU4Z46rmDT0r_m4DuKiDnZP1Dkaig4-xTDA-kA7THtGRnxOYS3Lz4yu74pcEnCGzqMlkkx_QlaCT_QMJ82vwCa0jD9ZBRDJD2u3hKZKAwzJmRSTpYNb7MFk3kCH4fdqRPgN8KLMZlNaZRWcSDENADY5kAyT4OAeMMecjma533plwsLaaXG8_biTROI7xonjdwxjx7fE-L359utluPpd332-_bK7vSs2VoiVTiFIB76BjVSVNL5o152tZ1Y3UmokatNZ9I0wne2GU1KZqqOhM0ytt1lSI8-LDMzeP-3vBmNrJxkMCcOiX2DJVV3UGZuHqWfh_pQH7dg52gvDUMtoeCmtzYe1LYfnD-yN56SY0L_JjW-If85OX7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17848265</pqid></control><display><type>article</type><title>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Watanabe, H ; de Caestecker, M P ; Yamada, Y</creator><creatorcontrib>Watanabe, H ; de Caestecker, M P ; Yamada, Y</creatorcontrib><description>In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation.</description><identifier>ISSN: 0021-9258</identifier><identifier>DOI: 10.1074/jbc.M005724200</identifier><identifier>PMID: 11278290</identifier><language>eng</language><publisher>United States</publisher><subject>Agc gene ; aggrecan ; Aggrecans ; Animals ; Butadienes - pharmacology ; Cell Differentiation ; Cell Line ; Cell Nucleus - metabolism ; Chondrocytes - cytology ; Cycloheximide - pharmacology ; DNA-Binding Proteins - metabolism ; Dose-Response Relationship, Drug ; Enzyme Activation ; ERK1 protein ; ERK2 protein ; Extracellular Matrix Proteins ; extracellular signal-regulated kinase ; Gene Expression Regulation, Enzymologic ; Genes, Dominant ; Imidazoles - pharmacology ; Immunoblotting ; Lectins, C-Type ; Luciferases - metabolism ; Mice ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 ; Mitogen-Activated Protein Kinases - metabolism ; Nitriles - pharmacology ; p38 Mitogen-Activated Protein Kinases ; Phosphorylation ; Protein Synthesis Inhibitors - pharmacology ; Proteoglycans - biosynthesis ; Pyridines - pharmacology ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction ; Smad Proteins ; Smad2 protein ; Thiazoles - pharmacology ; Time Factors ; Trans-Activators - metabolism ; Transcription, Genetic ; Transfection ; Transforming Growth Factor beta - metabolism</subject><ispartof>The Journal of biological chemistry, 2001-04, Vol.276 (17), p.14466-14473</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</citedby><cites>FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11278290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watanabe, H</creatorcontrib><creatorcontrib>de Caestecker, M P</creatorcontrib><creatorcontrib>Yamada, Y</creatorcontrib><title>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation.</description><subject>Agc gene</subject><subject>aggrecan</subject><subject>Aggrecans</subject><subject>Animals</subject><subject>Butadienes - pharmacology</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Cell Nucleus - metabolism</subject><subject>Chondrocytes - cytology</subject><subject>Cycloheximide - pharmacology</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Activation</subject><subject>ERK1 protein</subject><subject>ERK2 protein</subject><subject>Extracellular Matrix Proteins</subject><subject>extracellular signal-regulated kinase</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Genes, Dominant</subject><subject>Imidazoles - pharmacology</subject><subject>Immunoblotting</subject><subject>Lectins, C-Type</subject><subject>Luciferases - metabolism</subject><subject>Mice</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Nitriles - pharmacology</subject><subject>p38 Mitogen-Activated Protein Kinases</subject><subject>Phosphorylation</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>Proteoglycans - biosynthesis</subject><subject>Pyridines - pharmacology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Signal Transduction</subject><subject>Smad Proteins</subject><subject>Smad2 protein</subject><subject>Thiazoles - pharmacology</subject><subject>Time Factors</subject><subject>Trans-Activators - metabolism</subject><subject>Transcription, Genetic</subject><subject>Transfection</subject><subject>Transforming Growth Factor beta - metabolism</subject><issn>0021-9258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc1u1DAUhbMAtaVlyxJ5xaqZ-iceJ8tqKAVRhATDOrqxbzJuEzvYDtM-Im-Fh45UbyxZx985956ieMfoilFVXd13evWNUql4xSl9VZxRylnZcFmfFm9ivKf5VA07KU4Z46rmDT0r_m4DuKiDnZP1Dkaig4-xTDA-kA7THtGRnxOYS3Lz4yu74pcEnCGzqMlkkx_QlaCT_QMJ82vwCa0jD9ZBRDJD2u3hKZKAwzJmRSTpYNb7MFk3kCH4fdqRPgN8KLMZlNaZRWcSDENADY5kAyT4OAeMMecjma533plwsLaaXG8_biTROI7xonjdwxjx7fE-L359utluPpd332-_bK7vSs2VoiVTiFIB76BjVSVNL5o152tZ1Y3UmokatNZ9I0wne2GU1KZqqOhM0ytt1lSI8-LDMzeP-3vBmNrJxkMCcOiX2DJVV3UGZuHqWfh_pQH7dg52gvDUMtoeCmtzYe1LYfnD-yN56SY0L_JjW-If85OX7Q</recordid><startdate>20010427</startdate><enddate>20010427</enddate><creator>Watanabe, H</creator><creator>de Caestecker, M P</creator><creator>Yamada, Y</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TM</scope></search><sort><creationdate>20010427</creationdate><title>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</title><author>Watanabe, H ; de Caestecker, M P ; Yamada, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Agc gene</topic><topic>aggrecan</topic><topic>Aggrecans</topic><topic>Animals</topic><topic>Butadienes - pharmacology</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Cell Nucleus - metabolism</topic><topic>Chondrocytes - cytology</topic><topic>Cycloheximide - pharmacology</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Activation</topic><topic>ERK1 protein</topic><topic>ERK2 protein</topic><topic>Extracellular Matrix Proteins</topic><topic>extracellular signal-regulated kinase</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Genes, Dominant</topic><topic>Imidazoles - pharmacology</topic><topic>Immunoblotting</topic><topic>Lectins, C-Type</topic><topic>Luciferases - metabolism</topic><topic>Mice</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Nitriles - pharmacology</topic><topic>p38 Mitogen-Activated Protein Kinases</topic><topic>Phosphorylation</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>Proteoglycans - biosynthesis</topic><topic>Pyridines - pharmacology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Signal Transduction</topic><topic>Smad Proteins</topic><topic>Smad2 protein</topic><topic>Thiazoles - pharmacology</topic><topic>Time Factors</topic><topic>Trans-Activators - metabolism</topic><topic>Transcription, Genetic</topic><topic>Transfection</topic><topic>Transforming Growth Factor beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watanabe, H</creatorcontrib><creatorcontrib>de Caestecker, M P</creatorcontrib><creatorcontrib>Yamada, Y</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nucleic Acids Abstracts</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watanabe, H</au><au>de Caestecker, M P</au><au>Yamada, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2001-04-27</date><risdate>2001</risdate><volume>276</volume><issue>17</issue><spage>14466</spage><epage>14473</epage><pages>14466-14473</pages><issn>0021-9258</issn><abstract>In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation.</abstract><cop>United States</cop><pmid>11278290</pmid><doi>10.1074/jbc.M005724200</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2001-04, Vol.276 (17), p.14466-14473
issn 0021-9258
language eng
recordid cdi_proquest_miscellaneous_17848265
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Agc gene
aggrecan
Aggrecans
Animals
Butadienes - pharmacology
Cell Differentiation
Cell Line
Cell Nucleus - metabolism
Chondrocytes - cytology
Cycloheximide - pharmacology
DNA-Binding Proteins - metabolism
Dose-Response Relationship, Drug
Enzyme Activation
ERK1 protein
ERK2 protein
Extracellular Matrix Proteins
extracellular signal-regulated kinase
Gene Expression Regulation, Enzymologic
Genes, Dominant
Imidazoles - pharmacology
Immunoblotting
Lectins, C-Type
Luciferases - metabolism
Mice
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases - metabolism
Nitriles - pharmacology
p38 Mitogen-Activated Protein Kinases
Phosphorylation
Protein Synthesis Inhibitors - pharmacology
Proteoglycans - biosynthesis
Pyridines - pharmacology
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Smad Proteins
Smad2 protein
Thiazoles - pharmacology
Time Factors
Trans-Activators - metabolism
Transcription, Genetic
Transfection
Transforming Growth Factor beta - metabolism
title Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T02%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcriptional%20cross-talk%20between%20Smad,%20ERK1/2,%20and%20p38%20mitogen-activated%20protein%20kinase%20pathways%20regulates%20transforming%20growth%20factor-beta-induced%20aggrecan%20gene%20expression%20in%20chondrogenic%20ATDC5%20cells&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Watanabe,%20H&rft.date=2001-04-27&rft.volume=276&rft.issue=17&rft.spage=14466&rft.epage=14473&rft.pages=14466-14473&rft.issn=0021-9258&rft_id=info:doi/10.1074/jbc.M005724200&rft_dat=%3Cproquest_cross%3E17848265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17848265&rft_id=info:pmid/11278290&rfr_iscdi=true